BIOTEST ApS: Financial statements 2022
CVR: 26736994
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BIOTEST ApS (CVR 26736994) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -35,550 and a net result of DKK -390,731 compared with DKK 127,175 the year before. Equity in the 2022 report amounted to DKK 1,015,986. The solvency ratio was 70.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -35,550
- Profit/Loss
- DKK -390,731
- Equity
- DKK 1,015,986
- Total Assets
- DKK 1,436,030
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -36 t. | -391 t. | 1 mio. | 1 |
| 2021 | - | 272 t. | 127 t. | 1.5 mio. | 1 |
| 2020 | - | 399 t. | 280 t. | 1.5 mio. | 1 |
| 2019 | - | 79 t. | 263 t. | 1.3 mio. | - |
| 2018 | - | -61 t. | -126 t. | 1.2 mio. | - |
Official annual report
Keep an eye on BIOTEST ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BIOTEST ApS has published its annual report for 2021. Gross profit came to DKK 271,923, and the net result was DKK 127,175.
About BIOTEST ApS
BIOTEST ApS is a Danish company of the type Anpartsselskab based in Middelfart, founded in 2002. The company is registered under the industry Anden måling og teknisk analyse. The management consists of Pauli Lejf Kiel. The company is owned by Pauli Lejf Kiel. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -54,968 and a net result of DKK -65,376 compared with DKK 100,748 the year before. Equity in the 2025 report amounted to DKK 1,035,290.